Microglial Response to Brain Injury: A Brief Synopsis

In addition to astrocytes and oligodendrocytes, microglia represent the third major population of glial cells within the central nervous system (CNS). Microglia are distributed ubiquitously throughout the brain and spinal cord, and one of their main functions is to monitor and sustain neuronal health. Microglial cells are quite sensitive to even minor disturbances in CNS homeostasis, and they become readily activated during most neuropathologic conditions, including peripheral nerve injury, trauma and stroke, inflammatory disease, and neurotoxicant-induced neuronal injury. During activation, microglia display conspicuous functional plasticity, which involves changes in cell morphology, cell number, cell surface receptor expression, and production of growth factors and cytokines. The many changes occurring in activated cells reflect the altered functional states of microglia that are induced by signals arising from injured neurons. Thus, neuronal-microglial signaling plays a fundamental role in understanding how the CNS responds to injury. Reactive microgliosis should be viewed as a cellular effort to initiate ameliorative and reparative measures in the injured brain.

[1]  W. Streit,et al.  Reactive microgliosis , 1999, Progress in Neurobiology.

[2]  K. Black,et al.  Response of microglial cells to experimental rat glioma , 1992, Glia.

[3]  W. Streit,et al.  Tracing of fluoro‐gold prelabeled microglia injected into the adult rat brain , 1998, Glia.

[4]  Cytotoxicity of microglia , 1993 .

[5]  R. Lund,et al.  Differential induction of class I and II MHC antigen expression by degenerating myelinated and unmyelinated axons , 1990, Brain Research.

[6]  S. Thanos,et al.  The concept of microglia in relation to central nervous system disease and regeneration , 1996, Progress in Neurobiology.

[7]  M. Aschner,et al.  Glial cells in neurotoxicity development. , 1999, Annual review of pharmacology and toxicology.

[8]  D. Sparks,et al.  Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits , 1996, Journal of Molecular Medicine.

[9]  M. Graeber,et al.  CR3/43, a marker for activated human microglia: application to diagnostic neuropathology , 1994, Neuropathology and applied neurobiology.

[10]  W. Streit,et al.  The brain's immune system. , 1995, Scientific American.

[11]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[12]  W. Streit,et al.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Aschner Astrocytes as modulators of mercury-induced neurotoxicity. , 1996, Neurotoxicology.

[14]  D. Sparks,et al.  Ultrastructural Location of Major Histocompatibility Complex (MHC) Class II Positive Perivascular Cells in Histologically Normal Human Brain , 1992, Journal of neuropathology and experimental neurology.

[15]  G. Somjen Nervenkitt: Notes on the history of the concept of neuroglia , 1988, Glia.

[16]  M. Graeber,et al.  Identity of ED2‐positive perivascular cells in rat brain , 1989, Journal of neuroscience research.

[17]  W. Streit The role of microglia in brain injury. , 1996, Neurotoxicology.